Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
NCT ID: NCT03825458
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3500 participants
OBSERVATIONAL
2019-02-25
2029-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
NCT06906016
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
NCT05965388
Hepatitis B Research Network Adult Cohort Study
NCT01263587
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma
NCT02025842
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
NCT02148562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling
Blood sampling at each clinical follow-up visit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients requiring blood sampling for medical care at the time of the medical appointment.
* Informed patients who do not refuse to participate.
* Persons not affiliated to a social security scheme and persons receiving medical assistance from the state may be asked to participate in the study
Exclusion Criteria
* Persons deprived of their liberty by a judicial or administrative decision
* Adults who are subject to a legal protection measure
* Children less than 6 years old (in Lyon)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hepatology department - Groupement Hospitalier Nord - Hôpital de la Croix-Rousse
Lyon, , France
Hôpital de la Croix-Rousse - Service de maladies infectieuses et tropicales
Lyon, , France
Department of Hepato-gastroenterology and pediatric nutrition - Hôpital Femme-Mère Enfant
Lyon, , France
Gastroenterology and Hepatology department - • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, , Italy
Gastroenterology and Hepatology department - • Università degli Studi di Palermo
Palermo, , Italy
Infectious diseases and hepatology unit - Azienda Ospedaliero
Parma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02558-47
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL18_0436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.